EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study

Kishore M Gadde iD, Xiaoyan Yin iD, Ronald B Goldberg iD, Trevor J Orchard iD, Mathias Schlögl iD, Dana Dabelea iD, Uzoma N Ibebuogu iD, Karol E Watson iD, F Xavier Pi-Sunyer iD, Jill P Crandall iD, Marinella Temprosa iD, José A Luchsinger iD und 1 weitere

Journal of the American Heart Association · 2023

DOI: 10.1161/jaha.123.029671 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Kishore M Gadde und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery University of California, Irvine (UCI) Medical Center Orange CA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Metformin, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our aim was to investigate the association of coronary artery calcium (CAC) with cognitive function in adults with impaired glucose tolerance or type 2 diabetes. Methods and Results The Diabetes Prevention Program was a randomized controlled trial comparing an intensive lifestyle intervention, metformin, or placebo for prevention of type 2 diabetes among patients with prediabetes. After 3 years, intensive lifestyle intervention and placebo were stopped, the metformin arm was unmasked, and participants continued in the DPPOS (Diabetes Prevention Program Outcomes Study). Approximately 14 years after randomization (Y14), CAC (Agatston score) was assessed with computed tomography, and cognitive performance was assessed with the Spanish English Verbal Learning Test (SEVLT) and Digit Symbol Substitution Test. SEVLT and Digit Symbol Substitution Test were reassessed 5 years later (Y19) along with the Modified Mini‐Mental State Exam. We examined cross‐sectional and longitudinal associations between CAC and cognition among 1931 participants using linear and logistic regression. In unadjusted analyses, compared with no calcification, CAC score >300 was associated with decreased performance on all cognitive tests at Y14 in both sexes. Additionally, CAC >300 was associated with a greater 5‐year decline in SEVLT Immediate Recall in both sexes and SEVLT Delayed Recall in women. After adjustment for demographic, genetic, metabolic, vascular, and behavioral covariates, CAC score >300 remained associated with greater decline in only SEVLT Delayed Recall in women.

Conclusions

In women with prediabetes or diabetes, CAC >300, compared with no calcification, was independently associated with greater decline in verbal memory. Registration information clinicaltrials.gov . Identifier: NCT00038727.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Prediabetic StateMetforminCognitive DysfunctionCalcinosisCoronary Artery DiseaseVascular CalcificationMaleAdultHumansFemaleCalciumCoronary VesselsCross-Sectional StudiesCalcium, DietaryRisk Factors

Stichwörter der Autor:innen

cognitive impairmentcoronary artery calciumdiabetesprediabetessubclinical atherosclerosis

Substanzen

CalciumMetforminCalcium, Dietary

Autor:innen und Institutionen

  • Department of Surgery University of California, Irvine (UCI) Medical Center Orange CA.
  • Department of Biostatistics and Bioinformatics George Washington University Biostatistics Center Rockville MD.
  • Diabetes Research Institute, University of Miami Miller School of Medicine Miami FL.
  • University of Pittsburgh School of Public Health Pittsburgh PA.
  • Division of Geriatric Medicine, Clinic Barmelweid Barmelweid Switzerland.
  • Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center University of Colorado Anschutz Medical Campus Aurora CO.

ORCID-Profile: Kishore M Gadde, Xiaoyan Yin, Ronald B Goldberg, Trevor J Orchard, Mathias Schlögl, Dana Dabelea, Uzoma N Ibebuogu, Karol E Watson, F Xavier Pi-Sunyer, Jill P Crandall, Marinella Temprosa, José A Luchsinger

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS

Zitieren

APA

Gadde, K. M., Yin, X., Goldberg, R. B., Orchard, T. J., Schlögl, M., Dabelea, D., Ibebuogu, U. N., Watson, K. E., Pi-Sunyer, F. X., Crandall, J. P., Temprosa, M., Luchsinger, J. A., & Diabetes Prevention Program Research Group (2023). Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.029671

Vancouver

Gadde KM, Yin X, Goldberg RB, Orchard TJ, Schlögl M, Dabelea D, et al. Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study. Journal of the American Heart Association. 2023. doi:10.1161/jaha.123.029671

BibTeX
@article{Gadde2023,
  author = {Gadde, Kishore M and Yin, Xiaoyan and Goldberg, Ronald B and Orchard, Trevor J and Schlögl, Mathias and Dabelea, Dana and Ibebuogu, Uzoma N and Watson, Karol E and Pi-Sunyer, F Xavier and Crandall, Jill P and Temprosa, Marinella and Luchsinger, José A and Diabetes Prevention Program Research Group, Diabetes Prevention Program Research Group},
  title = {Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study},
  journal = {Journal of the American Heart Association},
  year = {2023},
  doi = {10.1161/jaha.123.029671}
}
Kostenlos starten →